SANTA MONICA, Calif., April 28, 2020 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced that it will report its financial results for the first quarter ended March 31, 2020, after the market close and host a corporate update conference call and webcast on Tuesday, May 12, at 4:30 p.m. Eastern Time.

Conference Call Details:
Tuesday, May 12^th at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time
Toll Free:                                877-407-0792
International:                          201-689-8263
Conference ID:                       13702897
Webcast:                                http://public.viavid.com/index.php?id=139556

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN^® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information, please visit: www.opiant.com.

CONTACTS:

For Investor and Media Inquiries:
Ben Atkins
Vice President, Communications and Investor Relations
Opiant Pharmaceuticals, Inc.
batkins@opiant.com
(310) 598-5410

Dan Ferry
Managing Director
LifeSci Advisors, LLC
Daniel@lifesciadvisors.com
(617) 430-7576

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.